High MMP-9 activity levels in fragile X syndrome are lowered by minocycline
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High MMP-9 activity levels in fragile X syndrome are lowered by minocycline
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF MEDICAL GENETICS PART A
Volume 161, Issue 8, Pages 1897-1903
Publisher
Wiley
Online
2013-07-04
DOI
10.1002/ajmg.a.36023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Randomized Double-Blind, Placebo-Controlled Trial of Minocycline in Children and Adolescents with Fragile X Syndrome
- (2013) Mary Jacena S. Leigh et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- Minocycline up-regulates the expression of brain-derived neurotrophic factor and nerve growth factor in experimental autoimmune encephalomyelitis
- (2012) Xiaohong Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Activity-Dependent Local Translation of Matrix Metalloproteinase-9
- (2012) M. Dziembowska et al. JOURNAL OF NEUROSCIENCE
- Understanding epileptogenesis in calcified neurocysticercosis with perfusion MRI
- (2012) R. K. Gupta et al. NEUROLOGY
- Targeting Neuro-Inflammatory Cytokines and Oxidative Stress by Minocycline Attenuates Quinolinic-Acid-Induced Huntington’s Disease-Like Symptoms in Rats
- (2012) Harikesh Kalonia et al. NEUROTOXICITY RESEARCH
- FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States
- (2012) Flora Tassone et al. Genome Medicine
- FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
- (2011) Jennifer C. Darnell et al. CELL
- Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase
- (2011) S. S. Siller et al. Disease Models & Mechanisms
- Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology
- (2011) P. Michaluk et al. JOURNAL OF CELL SCIENCE
- Targeted treatments for fragile X syndrome
- (2011) Elizabeth Berry-Kravis et al. Journal of Neurodevelopmental Disorders
- The prospects of minocycline in multiple sclerosis
- (2011) Xiaohong Chen et al. JOURNAL OF NEUROIMMUNOLOGY
- Association of MMP-2 and MMP-9 with clinical outcome of neurocysticercosis
- (2011) AVANTIKA VERMA et al. PARASITOLOGY
- Open-label add-on treatment trial of minocycline in fragile X syndrome
- (2010) Carlo Paribello et al. BMC Neurology
- Important role of matrix metalloproteinase 9 in epileptogenesis
- (2008) Grzegorz M. Wilczynski et al. JOURNAL OF CELL BIOLOGY
- Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately
- (2008) X.-b. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Rapid Polymerase Chain Reaction-Based Screening Method for Identification of All Expanded Alleles of the Fragile X (FMR1) Gene in Newborn and High-Risk Populations
- (2007) Flora Tassone et al. JOURNAL OF MOLECULAR DIAGNOSTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation